{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:26:07Z","timestamp":1790479567345,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nucleotide binding oligomerization domain 2 (NOD2) is a recognized innate immune sensor which can initiate potent immune response against pathogens. Many innate immune sensors have been reported to be of great importance in carcinogenesis. However, the role of NOD2 in cancer is not well understood. Here we investigated the role of NOD2 in the development of hepatocellular carcinoma (HCC). We demonstrated that NOD2 deficiency promoted hepatocarcinogenesis in <jats:italic>N<\/jats:italic>-nitrosodiethylamine (DEN)\/carbon tetrachloride (CCl<jats:sub>4<\/jats:sub>) induced HCC mice model and xenograft tumor model. In vitro investigation showed that NOD2 acted as a tumor suppressor and inhibited proliferation, colony formation and invasion of HCC cells. Clinical investigation showed that NOD2 expression was completely lost or significantly downregulated in clinical HCC tissues, and loss of NOD2 expression was significantly correlated with advanced disease stages. Further investigation showed that NOD2 exerted its anti-tumor effect through activating adenosine 5\u2032-monophosphate (AMP) -activated protein kinase (AMPK) signaling pathway, and NOD2 significantly enhanced the sensitivity of HCC cells to sorafenib, lenvatinib and 5-FU treatment through activating AMPK pathway induced apoptosis. Moreover, we demonstrated that NOD2 activated AMPK pathway by directly binding with AMPK\u03b1-LKB1 complex, which led to autophagy-mediated apoptosis of HCC cells. Altogether, this study showed that NOD2 acted as a tumor suppressor as well as a chemotherapeutic regulator in HCC cells by directly activating AMPK pathway, which indicated a potential therapeutic strategy for HCC treatment by upregulating NOD2-AMPK signaling axis.<\/jats:p>","DOI":"10.1038\/s41419-020-2368-5","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T15:06:48Z","timestamp":1583507208000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["NOD2 inhibits tumorigenesis and increases chemosensitivity of hepatocellular carcinoma by targeting AMPK pathway"],"prefix":"10.1038","volume":"11","author":[{"given":"Xiaomin","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueke","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dapeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,6]]},"reference":[{"key":"2368_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-018-0538-7","volume":"18","author":"K Lohitesh","year":"2018","unstructured":"Lohitesh, K., Chowdhury, R. & Mukherjee, S. Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight. Cancer Cell Int. 18, 44 (2018).","journal-title":"Cancer Cell Int."},{"key":"2368_CR2","doi-asserted-by":"publisher","first-page":"797","DOI":"10.4254\/wjh.v9.i18.797","volume":"9","author":"EU Cidon","year":"2017","unstructured":"Cidon, E. U. Systemic treatment of hepatocellular carcinoma: Past, present and future. World J. Hepatol. 9, 797\u2013807 (2017).","journal-title":"World J. Hepatol."},{"key":"2368_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.lfs.2019.04.039","volume":"227","author":"A Thirupathi","year":"2019","unstructured":"Thirupathi, A. & Chang, Y. Z. Role of AMPK and its molecular intermediates in subjugating cancer survival mechanism. Life Sci. 227, 30\u201338 (2019).","journal-title":"Life Sci."},{"key":"2368_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-019-0769-2","volume":"19","author":"BG Sanchez","year":"2019","unstructured":"Sanchez, B. G., Bort, A., Mateos-Gomez, P. A., Rodriguez-Henche, N. & Diaz-Laviada, I. Combination of the natural product capsaicin and docetaxel synergistically kills human prostate cancer cells through the metabolic regulator AMP-activated kinase. Cancer Cell Int. 19, 54 (2019).","journal-title":"Cancer Cell Int."},{"key":"2368_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.phrs.2019.03.011","volume":"144","author":"C Wei","year":"2019","unstructured":"Wei, C. et al. Cordycepin inhibits drug-resistance non-small cell lung cancer progression by activating AMPK signaling pathway. Pharm. Res. 144, 79\u201389 (2019).","journal-title":"Pharm. Res."},{"key":"2368_CR6","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/1878-0261.12488","volume":"13","author":"A Bort","year":"2019","unstructured":"Bort, A. et al. Targeting AMP-activated kinase impacts hepatocellular cancer stem cells induced by long-term treatment with sorafenib. Mol. Oncol. 13, 1311\u20131331 (2019).","journal-title":"Mol. Oncol."},{"key":"2368_CR7","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.immuni.2014.12.010","volume":"41","author":"R Caruso","year":"2014","unstructured":"Caruso, R., Warner, N., Inohara, N. & Nunez, G. NOD1 and NOD2: signaling, host defense, and inflammatory disease. Immunity 41, 898\u2013908 (2014).","journal-title":"Immunity"},{"key":"2368_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3109\/08830185.2013.777064","volume":"32","author":"J Pothlichet","year":"2013","unstructured":"Pothlichet, J. & Quintana-Murci, L. The genetics of innate immunity sensors and human disease. Int Rev. Immunol. 32, 157\u2013208 (2013).","journal-title":"Int Rev. Immunol."},{"key":"2368_CR9","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/labinvest.2015.63","volume":"95","author":"Q Wei","year":"2015","unstructured":"Wei, Q. et al. Estrogen suppresses hepatocellular carcinoma cells through ERbeta-mediated upregulation of the NLRP3 inflammasome. Lab Invest. 95, 804\u2013816 (2015).","journal-title":"Lab Invest."},{"key":"2368_CR10","doi-asserted-by":"crossref","first-page":"36185","DOI":"10.18632\/oncotarget.9154","volume":"7","author":"X Ma","year":"2016","unstructured":"Ma, X. et al. Loss of AIM2 expression promotes hepatocarcinoma progression through activation of mTOR-S6K1 pathway. Oncotarget 7, 36185\u201336197 (2016).","journal-title":"Oncotarget"},{"key":"2368_CR11","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.humimm.2011.06.003","volume":"72","author":"AG Kutikhin","year":"2011","unstructured":"Kutikhin, A. G. Role of NOD1\/CARD4 and NOD2\/CARD15 gene polymorphisms in cancer etiology. Hum. Immunol. 72, 955\u2013968 (2011).","journal-title":"Hum. Immunol."},{"key":"2368_CR12","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/med.21557","volume":"39","author":"S Nabergoj","year":"2019","unstructured":"Nabergoj, S., Mlinaric-Rascan, I. & Jakopin, Z. Harnessing the untapped potential of nucleotide-binding oligomerization domain ligands for cancer immunotherapy. Med Res. Rev. 39, 1447\u20131484 (2019).","journal-title":"Med Res. Rev."},{"key":"2368_CR13","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","volume":"21","author":"DH Dapito","year":"2012","unstructured":"Dapito, D. H. et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 21, 504\u2013516 (2012).","journal-title":"Cancer Cell"},{"key":"2368_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep06248","volume":"4","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression. Sci. Rep. 4, 6248 (2014).","journal-title":"Sci. Rep."},{"key":"2368_CR15","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/onc.2017.349","volume":"37","author":"P Guo","year":"2018","unstructured":"Guo, P. et al. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex. Oncogene 37, 478\u2013488 (2018).","journal-title":"Oncogene"},{"key":"2368_CR16","doi-asserted-by":"publisher","first-page":"8869","DOI":"10.1074\/jbc.C200651200","volume":"278","author":"SE Girardin","year":"2003","unstructured":"Girardin, S. E. et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278, 8869\u20138872 (2003).","journal-title":"J. Biol. Chem."},{"key":"2368_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13046-018-0731-5","volume":"37","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Metformin induces autophagy and G0\/G1 phase cell cycle arrest in myeloma by targeting the AMPK\/mTORC1 and mTORC2 pathways. J. Exp. Clin. Cancer Res. 37, 63 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2368_CR18","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/15548627.2016.1140293","volume":"12","author":"JM Park","year":"2016","unstructured":"Park, J. M. et al. The ULK1 complex mediates MTORC1 signaling to the autophagy initiation machinery via binding and phosphorylating ATG14. Autophagy 12, 547\u2013564 (2016).","journal-title":"Autophagy"},{"key":"2368_CR19","doi-asserted-by":"publisher","unstructured":"Colhado Rodrigues, B. L., Lallo, M. A. & Perez, E. C. The controversial role of autophagy in tumor development: a systematic review. Immunol Invest. 1\u201311, https:\/\/doi.org\/10.1080\/08820139.2019.1682600 (2019).","DOI":"10.1080\/08820139.2019.1682600"},{"issue":"10","key":"2368_CR20","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3390\/nu8100546","volume":"8","author":"Zhengdong Jiang","year":"2016","unstructured":"Jiang, Z. et al. YAP inhibition by resveratrol via activation of AMPK enhances the sensitivity of pancreatic cancer cells to gemcitabine. Nutrients 8, https:\/\/doi.org\/10.3390\/nu8100546 (2016).","journal-title":"Nutrients"},{"key":"2368_CR21","first-page":"2880","volume":"18","author":"JB Park","year":"2018","unstructured":"Park, J. B. et al. Corosolic acid reduces 5FU chemoresistance in human gastric cancer cells by activating AMPK. Mol. Med. Rep. 18, 2880\u20132888 (2018).","journal-title":"Mol. Med. Rep."},{"key":"2368_CR22","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3389\/fphar.2019.00843","volume":"10","author":"Y Pan","year":"2019","unstructured":"Pan, Y. et al. CTAB enhances chemo-sensitivity through activation of AMPK signaling cascades in breast cancer. Front Pharm. 10, 843 (2019).","journal-title":"Front Pharm."},{"key":"2368_CR23","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet, J. M. et al. Sorafenib in advanced hepatocellular carcinoma. N. Engl. J. Med. 359, 378\u2013390 (2008).","journal-title":"N. Engl. J. Med."},{"key":"2368_CR24","doi-asserted-by":"publisher","first-page":"20249","DOI":"10.1002\/jcp.28625","volume":"234","author":"M Li","year":"2019","unstructured":"Li, M. et al. Aluminum chloride causes 5-fluorouracil resistance in hepatocellular carcinoma HepG2 cells. J. Cell Physiol. 234, 20249\u201320265 (2019).","journal-title":"J. Cell Physiol."},{"key":"2368_CR25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cld.2015.01.009","volume":"19","author":"A Kalyan","year":"2015","unstructured":"Kalyan, A., Nimeiri, H. & Kulik, L. Systemic therapy of hepatocellular carcinoma: current and promising. Clin. Liver Dis. 19, 421\u2013432 (2015).","journal-title":"Clin. Liver Dis."},{"key":"2368_CR26","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/ncb3255","volume":"17","author":"R Lin","year":"2015","unstructured":"Lin, R. et al. 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling. Nat. Cell Biol. 17, 1484\u20131496 (2015).","journal-title":"Nat. Cell Biol."},{"key":"2368_CR27","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.micinf.2010.05.006","volume":"12","author":"MS Frutuoso","year":"2010","unstructured":"Frutuoso, M. S. et al. The pattern recognition receptors Nod1 and Nod2 account for neutrophil recruitment to the lungs of mice infected with Legionella pneumophila. Microbes Infect. 12, 819\u2013827 (2010).","journal-title":"Microbes Infect."},{"key":"2368_CR28","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1172\/JCI57761","volume":"121","author":"KM Davis","year":"2011","unstructured":"Davis, K. M., Nakamura, S. & Weiser, J. N. Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice. J. Clin. Invest. 121, 3666\u20133676 (2011).","journal-title":"J. Clin. Invest."},{"key":"2368_CR29","doi-asserted-by":"publisher","first-page":"12873","DOI":"10.1073\/pnas.0904958106","volume":"106","author":"P Hruz","year":"2009","unstructured":"Hruz, P. et al. NOD2 contributes to cutaneous defense against Staphylococcus aureus through alpha-toxin-dependent innate immune activation. Proc. Natl Acad. Sci. USA 106, 12873\u201312878 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2368_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cyto.2016.01.021","volume":"89","author":"KV Korneev","year":"2017","unstructured":"Korneev, K. V. et al. TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis. Cytokine 89, 127\u2013135 (2017).","journal-title":"Cytokine"},{"key":"2368_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48794-x","volume":"9","author":"HE Lee","year":"2019","unstructured":"Lee, H. E. et al. Inhibition of NLRP3 inflammasome in tumor microenvironment leads to suppression of metastatic potential of cancer cells. Sci. Rep. 9, 12277 (2019).","journal-title":"Sci. Rep."},{"key":"2368_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1447-y","volume":"10","author":"Q Yu","year":"2019","unstructured":"Yu, Q. et al. Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment. Cell Death Dis. 10, 218 (2019).","journal-title":"Cell Death Dis."},{"key":"2368_CR33","first-page":"274","volume":"23","author":"Y Liu","year":"2019","unstructured":"Liu, Y., Li, H., Li, L. H., Tang, J. B. & Sheng, Y. L. Mir-451 inhibits proliferation and migration of non-small cell lung cancer cells via targeting LKB1\/AMPK. Eur. Rev. Med Pharm. Sci. 23, 274\u2013280 (2019).","journal-title":"Eur. Rev. Med Pharm. Sci."},{"key":"2368_CR34","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.bbrc.2019.07.049","volume":"517","author":"K Taniguchi","year":"2019","unstructured":"Taniguchi, K. et al. Depletion of gamma-glutamylcyclotransferase inhibits cancer cell growth by activating the AMPK-FOXO3a-p21 axis. Biochem. Biophys. Res. Co. 517, 238\u2013243 (2019).","journal-title":"Biochem. Biophys. Res. Co."},{"key":"2368_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2019.08.003","volume":"463","author":"G Fang","year":"2019","unstructured":"Fang, G. et al. Inhibition of GSK-3beta activity suppresses HCC malignant phenotype by inhibiting glycolysis via activating AMPK\/mTOR signaling. Cancer Lett. 463, 11\u201326 (2019).","journal-title":"Cancer Lett."},{"key":"2368_CR36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/hep.25989","volume":"57","author":"X Sun","year":"2013","unstructured":"Sun, X. et al. Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39\/ENTPD1 null mice. Hepatology 57, 205\u2013216 (2013).","journal-title":"Hepatology"},{"key":"2368_CR37","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.ccell.2015.04.001","volume":"27","author":"F Li","year":"2015","unstructured":"Li, F. et al. LKB1 inactivation elicits a redox imbalance to modulate non-small cell lung cancer plasticity and therapeutic response. Cancer Cell 27, 698\u2013711 (2015).","journal-title":"Cancer Cell"},{"key":"2368_CR38","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.1172\/JCI82152","volume":"125","author":"CG Pena","year":"2015","unstructured":"Pena, C. G. et al. LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment. J. Clin. Invest. 125, 4063\u20134076 (2015).","journal-title":"J. Clin. Invest."},{"key":"2368_CR39","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/onc.2017.354","volume":"37","author":"X Zheng","year":"2018","unstructured":"Zheng, X. et al. Aurora-A-mediated phosphorylation of LKB1 compromises LKB1\/AMPK signaling axis to facilitate NSCLC growth and migration. Oncogene 37, 502\u2013511 (2018).","journal-title":"Oncogene"},{"key":"2368_CR40","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.molcel.2015.03.020","volume":"58","author":"S Chauhan","year":"2015","unstructured":"Chauhan, S., Mandell, M. A. & Deretic, V. IRGM governs the core autophagy machinery to conduct antimicrobial defense. Mol. Cell 58, 507\u2013521 (2015).","journal-title":"Mol. Cell"},{"key":"2368_CR41","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/15548627.2017.1389823","volume":"14","author":"AC Racanelli","year":"2018","unstructured":"Racanelli, A. C., Kikkers, S. A., Choi, A. M. K. & Cloonan, S. M. Autophagy and inflammation in chronic respiratory disease. Autophagy 14, 221\u2013232 (2018). 2017.1389823.","journal-title":"Autophagy"},{"key":"2368_CR42","doi-asserted-by":"publisher","first-page":"108892","DOI":"10.1016\/j.biopha.2019.108892","volume":"115","author":"A Udristioiu","year":"2019","unstructured":"Udristioiu, A. & Nica-Badea, D. Autophagy dysfunctions associated with cancer cells and their therapeutic implications. Biomed. Pharmacother. 115, 108892 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"2368_CR43","doi-asserted-by":"publisher","first-page":"825","DOI":"10.5604\/01.3001.0010.4672","volume":"71","author":"D Kasprowska-Liskiewicz","year":"2017","unstructured":"Kasprowska-Liskiewicz, D. The cell on the edge of life and death: crosstalk between autophagy and apoptosis. Postepy Hig. Med. Dosw. (Online) 71, 825\u2013841 (2017).","journal-title":"Postepy Hig. Med. Dosw. (Online)"},{"key":"2368_CR44","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.canlet.2017.09.049","volume":"411","author":"S Yu","year":"2017","unstructured":"Yu, S. et al. Autophagy in the \u201cinflammation-carcinogenesis\u201d pathway of liver and HCC immunotherapy. Cancer Lett. 411, 82\u201389 (2017).","journal-title":"Cancer Lett."},{"key":"2368_CR45","doi-asserted-by":"publisher","first-page":"5162","DOI":"10.1021\/acs.jmedchem.7b00608","volume":"60","author":"S Wang","year":"2017","unstructured":"Wang, S. et al. Discovery of 1,4-benzodiazepine-2,5-dione (BZD) derivatives as dual nucleotide binding oligomerization domain containing 1\/2 (NOD1\/NOD2) antagonists sensitizing paclitaxel (PTX) To suppress lewis lung carcinoma (LLC) growth in vivo. J. Med. Chem. 60, 5162\u20135192 (2017).","journal-title":"J. Med. Chem."},{"key":"2368_CR46","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1021\/acs.jmedchem.6b01704","volume":"60","author":"Y Dong","year":"2017","unstructured":"Dong, Y. et al. Antagonizing NOD2 signaling with conjugates of paclitaxel and muramyl dipeptide derivatives sensitizes paclitaxel therapy and significantly prevents tumor metastasis. J. Med. Chem. 60, 1219\u20131224 (2017).","journal-title":"J. Med. Chem."},{"key":"2368_CR47","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1021\/acs.jmedchem.7b01407","volume":"61","author":"X Wen","year":"2018","unstructured":"Wen, X. et al. Salutaxel, a conjugate of docetaxel and a muramyl dipeptide (MDP) analogue, acts as multifunctional prodrug that inhibits tumor growth and metastasis. J. Med Chem. 61, 1519\u20131540 (2018).","journal-title":"J. Med Chem."},{"key":"2368_CR48","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.molcel.2018.01.016","volume":"69","author":"T Goncharov","year":"2018","unstructured":"Goncharov, T. et al. Disruption of XIAP-RIP2 association blocks NOD2-mediated inflammatory signaling. Mol. Cell 69, 551\u2013565 e557 (2018).","journal-title":"Mol. Cell"},{"key":"2368_CR49","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/labinvest.2013.126","volume":"94","author":"Q Wei","year":"2014","unstructured":"Wei, Q. et al. Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression. Lab Invest. 94, 52\u201362 (2014).","journal-title":"Lab Invest."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2368-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2368-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2368-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:49:08Z","timestamp":1670251748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2368-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,6]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["2368"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2368-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,6]]},"assertion":[{"value":"24 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"174"}}